Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Celsus Medica AB
AB
Active
Org 5594291931
Granelidsvägen 17 A
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 10K
-91% vs 2024
EBITDA margin
-124.4%
-113% vs 2024
Equity ratio
98.7%
Financial strength
Net profit 2025
SEK 2,1M
-4% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 10K
-91%
EBITDA
SEK -12K
-113%
Net profit
SEK 2,1M
-4%
Total assets
SEK 3,9M
+71%
Equity
SEK 3,8M
+73%
Employees
0
—
Company information
Legal name
Celsus Medica AB
Org number
5594291931
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 april 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Företaget ska bedriva medicinsk verksamhet i huvudsak med inriktning inom kirurgi. Även till viss del medicinsk forskning.
Contact
Address
Granelidsvägen 17 A
Email
peterakerud@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
32
108
10
Staff expenses
—
—
−0
EBITDA
13
93
−12
Depreciation & amort.
—
—
—
EBIT
13
93
−12
Net financials
—
2 120
2 104
Profit before tax
13
2 213
2 105
Tax
−3
−23
−1
Net profit
11
2 190
2 104
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
62
2 278
3 898
Equity
36
2 226
3 846
Long-term debt
—
—
—
Short-term debt
27
52
52
Total debt
27
52
52
Financial ratios
5-year trend
EBITDA margin
-124.4%
This company
15.8%
Market median
-887% vs market
2023
2025
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
2023
2025
Return on equity
54.7%
This company
18.4%
Market median
+197% vs market
2023
2025
Net profit margin
21036.3%
This company
8.1%
Market median
+259607% vs market
2023
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-04-04 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AM
Anne Marie Svedare
Chief Auditor
Chief Auditor
2025
JP
Jan Peter Mikael Åkerud
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
GH
Gustav Harald Rurik Åkerud
Deputy Board Member
2023
EO
Erik Oskar Alarik Åkerud
Deputy Board Member
2023
ÅH
Åsa Helena Åkerud Larsson
Deputy Board Member
2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Celsus Medica AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anne Marie Svedare
Chief Auditor
0 companies
Jan Peter Mikael Åkerud
Chief Executive Officer
0 companies
Gustav Harald Rurik Åkerud
Deputy Board Member
0 companies
Erik Oskar Alarik Åkerud
Deputy Board Member
0 companies
Åsa Helena Åkerud Larsson
Deputy Board Member
0 companies